Universal Lipid Screening Among 9- to 11-Year-Old Children: Screening Results and Physician Management

Area of Science:

• Pediatrics
• Public Health
• Cardiovascular Health

Background:

• Universal lipid screening (ULS) is recommended for children aged 9-11.
• Current screening practices and long-term management by pediatricians require investigation.

Purpose of the Study:

• To evaluate the outcomes of ULS in children aged 9-11.
• To assess pediatrician management of pediatric dyslipidemia following ULS.
• To identify gaps in screening completion and follow-up care.

Main Methods:

• Retrospective chart review of well-child visits between 2014-2016.
• Descriptive statistics for demographics, ULS results, and follow-up data.
• Pearson chi-squared test to compare groups with and without abnormal screens.

Main Results:

• Only 33.3% of eligible children completed ULS.
• 18.1% of screened children had abnormal results; 10.2% had dyslipidemia.
• Children with dyslipidemia had suboptimal follow-up: 68.6% had follow-up visits, 31.4% had repeat testing.

Conclusions:

• Low ULS completion rates and inconsistent follow-up management challenge the effectiveness of ULS.
• Pediatricians need enhanced strategies for universal testing and long-term dyslipidemia management.
• Point-of-care testing and improved management protocols could optimize ULS effectiveness.